Search Results 1-10 of 28671 for what is vedolizumab

  1. Vedolizumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Descriptions. Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a monoclonal antibody ...

  2. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), ...

  3. Ulcerative colitis - Diagnosis and treatment - Mayo Clinic

    Endoscopic procedures with tissue biopsy are the only way to definitively diagnose ulcerative colitis. Other types of tests can help rule out complications ...

  4. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...

  5. Vedolizumab (Intravenous Route, Subcutaneous Route) Before Using - Mayo Clinic

    Infection—May decrease your body's ability to fight an infection. Description and Brand Names · Proper Use. Portions of this document last updated ...

  6. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Vedolizumab (Entyvio). This drug works by stopping certain immune cell molecules — integrins — from binding to other cells in your intestinal lining.

  7. Ulcerative colitis - Symptoms and causes - Mayo Clinic

    Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in your digestive tract.

  8. Vedolizumab (Intravenous Route, Subcutaneous Route) Proper Use - Mayo Clinic

    For injection dosage form (prefilled pen or prefilled syringe):. For ulcerative colitis: Adults—The first 2 doses are given by a doctor through a needle placed ...

  9. Vedolizumab (Intravenous Route, Subcutaneous Route) Precautions - Mayo Clinic

    If your condition does not improve within 14 weeks, or if it become worse, check with your doctor. Vedolizumab may cause an infusion reaction while you are ...

  10. Vedolizumab (Intravenous Route, Subcutaneous Route) Side Effects - Mayo Clinic

    Rare · Cough · difficulty with swallowing · dizziness · fast heartbeat · hives, itching, or skin rash · puffiness or swelling of the eyelids or around the eyes, face, ...